Literature DB >> 28432130

Do the Microbiota Influence Vaccines and Protective Immunity to Pathogens? Engaging Our Endogenous Adjuvants.

Nicholas Collins1, Yasmine Belkaid1,2.   

Abstract

The reliance of the immune system on constitutive microbial stimulation support the idea that both responsiveness to vaccines and vaccine design need to be considered in the context of host-microbiota interactions. Manipulation of microbe function or composition via diet alteration or microbiota engraftment may soon become a viable approach to control immunity and, as such, vaccine responses. Learning from our endogenous original adjuvants could be critical in overcoming the enormous hurdle of vaccine design against the numerous pathogens that cause chronic infection. Going forward, rationally designed vaccines that take advantage of the inherent adjuvant properties of the microbiota could have a major impact on the prevention of disease.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28432130     DOI: 10.1101/cshperspect.a028860

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  12 in total

1.  Housing conditions and microbial environment do not affect the efficacy of vaccines for treatment of opioid use disorders in mice and rats.

Authors:  Bethany Crouse; Li Zhang; Christine Robinson; Yuguang Ban; Jennifer R Vigliaturo; Sabita Roy; Marco Pravetoni
Journal:  Hum Vaccin Immunother       Date:  2021-08-19       Impact factor: 4.526

2.  Mucosal microbial parasites/symbionts in health and disease: an integrative overview.

Authors:  Robert P Hirt
Journal:  Parasitology       Date:  2019-08       Impact factor: 3.234

3.  Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans.

Authors:  Thomas Hagan; Mario Cortese; Nadine Rouphael; Carolyn Boudreau; Caitlin Linde; Mohan S Maddur; Jishnu Das; Hong Wang; Jenna Guthmiller; Nai-Ying Zheng; Min Huang; Amit A Uphadhyay; Luiz Gardinassi; Caroline Petitdemange; Michele Paine McCullough; Sara Jo Johnson; Kiran Gill; Barbara Cervasi; Jun Zou; Alexis Bretin; Megan Hahn; Andrew T Gewirtz; Steve E Bosinger; Patrick C Wilson; Shuzhao Li; Galit Alter; Surender Khurana; Hana Golding; Bali Pulendran
Journal:  Cell       Date:  2019-09-05       Impact factor: 41.582

Review 4.  The Significance of the Intestinal Microbiome for Vaccinology: From Correlations to Therapeutic Applications.

Authors:  Vanessa C Harris
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

Review 5.  Emerging concepts in the science of vaccine adjuvants.

Authors:  Bali Pulendran; Prabhu S Arunachalam; Derek T O'Hagan
Journal:  Nat Rev Drug Discov       Date:  2021-04-06       Impact factor: 84.694

Review 6.  The aging gut microbiome and its impact on host immunity.

Authors:  Nabil Bosco; Mario Noti
Journal:  Genes Immun       Date:  2021-04-19       Impact factor: 2.676

7.  Host Transcriptome and Microbiota Signatures Prior to Immunization Profile Vaccine Humoral Responsiveness.

Authors:  Elena Gonçalves; Yolanda Guillén; Javier R Lama; Jorge Sanchez; Christian Brander; Roger Paredes; Behazine Combadière
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

Review 8.  Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design.

Authors:  Jean-Pierre Routy; Vikram Mehraj
Journal:  AIDS Res Ther       Date:  2017-09-12       Impact factor: 2.250

Review 9.  The Mammalian Intestinal Microbiome: Composition, Interaction with the Immune System, Significance for Vaccine Efficacy, and Potential for Disease Therapy.

Authors:  Ulrich Desselberger
Journal:  Pathogens       Date:  2018-06-21

10.  Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination.

Authors:  Jacob A Cram; Andrew J Fiore-Gartland; Sujatha Srinivasan; Shelly Karuna; Giuseppe Pantaleo; Georgia D Tomaras; David N Fredricks; James G Kublin
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.